Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease

Published:2017-06-06 Issue:5 Volume:1 Page:421-428
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Younossi Zobair M.¹²^ORCID,Stepanova Maria³²,Rafiq Nila¹²,Henry Linda³²,Loomba Rohit⁴,Makhlouf Hala⁵,Goodman Zachary¹²

Affiliation:

1. Center for Liver Diseases, Department of Medicine; Inova Fairfax Hospital; Falls Church VA

2. Betty and Guy Beatty Center for Integrated Research; Inova Health System; Falls Church VA

3. Center for Outcomes Research in Liver Diseases; Washington DC

4. NAFLD Research Center; University of California San Diego; San Diego CA

5. Cancer Diagnosis Program, National Cancer Institute; National Institutes of Health; Bethesda MD

Publisher

Wiley

Subject

Hepatology

Reference34 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

2. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

3. Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD);Stepanova;Dig Dis Sci,2013

4. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association;Chalasani;Hepatology.,2012

5. Long-term follow-up of patients with nonalcoholic fatty liver;Rafiq;Clin Gastroenterol Hepatol,2009

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of LH10, a novel fexaramine-based FXR agonist for the treatment of liver disease;Bioorganic Chemistry;2024-02

2. Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions;Radiology;2024-01-01

3. Utility of pathologist panels for achieving consensus in NASH histologic scoring in clinical trials: Data from a phase 3 study;Hepatology Communications;2023-12-22

4. Object detection: A novel AI technology for the diagnosis of hepatocyte ballooning;Liver International;2023-11-28

5. The quest for the ideal NASH biomarker;The Lancet Gastroenterology & Hepatology;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3